You searched for "UKEGS"

200 results found

My Top Five: Ophthalmology Twitter accounts

There are approximately 4.2 billion active social media users worldwide. This figure represents over half of the global population and is steadily rising [1]. There are currently over 217 million active Twitter users and given the platform’s versatility and ability...

Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals

Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...

Cutting-edge practice in glaucoma care: what, how and why?

More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)

Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

Semaglutide and vision loss: A new concern for NAION risk?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

The National Treatment Centre-Highland

The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

Updated Guidance for Professional Practice published by College of Optometrists

The College of Optometrists has today (11 December) published updated Guidance for Professional Practice for optometrists, including new sections.

ARU opens Sensory Sciences Centre in Cambridge

New £1.9m investment in equipment, teaching and research space for students.

New free eye test service is open and accepting bookings

We at Vision Care for Homeless People (VCHP) are pleased to announce that our brand-new clinic is now open and accepting bookings for free eye tests and spectacles. We are based at the Crisis Skylight building on Canongate in Edinburgh,...

Orbis UK release 2024 highlights video

Orbis UK have released their 2024 highlights video, revealing some of the incredible achievements their supporters helped make possible last year. The Orbis Flying Eye Hospital completed two sight-saving missions to Mongolia and Bangladesh. Orbis's clinical staff and Volunteer medical...

Thomas Pocklington Trust and Guide Dogs expands student support services to include younger age group

Sight loss charities, Guide Dogs and Thomas Pocklington Trust (TPT) are working together to deliver advice and guidance to blind and partially sighted students, their families and carers and any professionals that support them. The two charities have partnered to...